Advancell Advanced In Vitro Cell Technologies
Barcelona
About Advancell Advanced In Vitro Cell Technologies
Advanced In Vitro Cell Technologies a biotech nanomedicine company, engages in the development of drugs through the search for new applications for already-known molecules, and services and reagents. It also develops and markets in vitro cell models with a regulatory and/or predictive value. In addition, the company offers research services; safety assessment of cosmetic raw materials and finished products; vitro services for toxicological evaluation and advising; integrated and customized research for absorption, distribution, metabolism, and elimination; skin biology and cosmetics; anti-tumoural activity of compounds; anti-inflammatory activity of new compounds and cell responses to inflammatory stimuli; biocompatibility for evaluating biocompatible materials; CacoReady system, an integral tool designed to optimize time and costs for intestinal absorption evaluation of compounds; CacoGoblet cell model that combines the absorbent qualities of Caco2 cells with a mucosecreting cell line; TransportPlus, a ready-to-use system for in vitro comparative absorption profiling; AdipoReady kit, an in vitro model for studying the toxicity of metabolites derived from the action of cytochrome P-450 isoenzymes in a ready-to-use system; and liver, lung, and human skin microsomes. Advanced In Vitro Cell Technologies S.L. was founded in 2001 and is based in Barcelona, Spain.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.2M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2007)
- Website: advancell.net
- Phone: +34 93 403 45 45
Industries & Categories
Biotechnology, Health Care, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/advancell-advanced-in-vitro-cell-technologies-3096711 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.